C2orf42
gene geneOn this page
Also known as FLJ20558
Summary
C2orf42 (chromosome 2 open reading frame 42, HGNC:26056) is a protein-coding gene on chromosome 2p13.3, encoding Uncharacterized protein C2orf42 (Q9NWW7).
Located in nucleoplasm.
Source: NCBI Gene 54980 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 18 total
- MANE Select transcript:
NM_017880
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26056 |
| Approved symbol | C2orf42 |
| Name | chromosome 2 open reading frame 42 |
| Location | 2p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20558 |
| Ensembl gene | ENSG00000115998 |
| Ensembl biotype | protein_coding |
| Entrez | 54980 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 14 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000264434, ENST00000417203, ENST00000417865, ENST00000419381, ENST00000420306, ENST00000425268, ENST00000428010, ENST00000428751, ENST00000447804, ENST00000457952, ENST00000464505, ENST00000470096, ENST00000487560, ENST00000495353, ENST00000884989, ENST00000884990, ENST00000923678, ENST00000967691
RefSeq mRNA: 8 — MANE Select: NM_017880
NM_001348758, NM_001348759, NM_001348760, NM_001348761, NM_001348762, NM_001348763, NM_001348764, NM_017880
CCDS: CCDS1899
Canonical transcript exons
ENST00000264434 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000759560 | 70175673 | 70175777 |
| ENSE00000759574 | 70169557 | 70169661 |
| ENSE00000759598 | 70165528 | 70165635 |
| ENSE00000846491 | 70179532 | 70179642 |
| ENSE00000846492 | 70181163 | 70181997 |
| ENSE00000963062 | 70165092 | 70165192 |
| ENSE00000963063 | 70160625 | 70160787 |
| ENSE00000963064 | 70149885 | 70150564 |
| ENSE00001164252 | 70182667 | 70182935 |
| ENSE00001164257 | 70190973 | 70191019 |
Expression profiles
Bgee: expression breadth ubiquitous, 265 present calls, max score 97.36.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9131 / max 57.4145, expressed in 1617 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 29020 | 36.5786 | 1822 |
| 29013 | 2.3389 | 1328 |
| 29011 | 1.1751 | 697 |
| 29012 | 0.3991 | 186 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.36 | gold quality |
| male germ cell | CL:0000015 | 95.53 | gold quality |
| left testis | UBERON:0004533 | 92.34 | gold quality |
| right testis | UBERON:0004534 | 92.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.64 | gold quality |
| testis | UBERON:0000473 | 91.03 | gold quality |
| adult organism | UBERON:0007023 | 87.10 | gold quality |
| granulocyte | CL:0000094 | 85.37 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.60 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.68 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.33 | gold quality |
| right uterine tube | UBERON:0001302 | 81.32 | gold quality |
| prefrontal cortex | UBERON:0000451 | 81.06 | gold quality |
| ventricular zone | UBERON:0003053 | 81.06 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 81.04 | gold quality |
| cerebellar cortex | UBERON:0002129 | 81.03 | gold quality |
| colonic epithelium | UBERON:0000397 | 80.99 | gold quality |
| lymph node | UBERON:0000029 | 80.60 | gold quality |
| cerebellum | UBERON:0002037 | 80.24 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.13 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.84 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.72 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.31 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 79.30 | gold quality |
| secondary oocyte | CL:0000655 | 79.29 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 79.27 | gold quality |
| gall bladder | UBERON:0002110 | 79.16 | gold quality |
| leukocyte | CL:0000738 | 78.98 | gold quality |
| liver | UBERON:0002107 | 78.87 | gold quality |
| body of uterus | UBERON:0009853 | 78.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
50 targeting C2orf42, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-609 | 99.82 | 64.26 | 505 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | C5H2orf42 | ENSDARG00000059636 |
| mus_musculus | C87436 | ENSMUSG00000046679 |
| rattus_norvegicus | C4h2orf42 | ENSRNOG00000017380 |
| drosophila_melanogaster | CG2321 | FBGN0039663 |
Protein
Protein identifiers
Uncharacterized protein C2orf42 — Q9NWW7 (reviewed: Q9NWW7)
All UniProt accessions (9): Q9NWW7, C9J4L7, C9J5U1, C9JJF4, C9JK51, C9JKD5, C9JS43, C9JV10, C9JZF3
RefSeq proteins (8): NP_001335687, NP_001335688, NP_001335689, NP_001335690, NP_001335691, NP_001335692, NP_001335693, NP_060350* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026049 | C2orf42 | Family |
| IPR029269 | Zf-tcix | Domain |
Pfam: PF14952
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NWW7-F1 | 74.37 | 0.39 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 107 (showing top):
RNGTGGGC_UNKNOWN, ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, NERF_Q2, TTTGCAC_MIR19A_MIR19B, CHEN_HOXA5_TARGETS_9HR_UP, SCGGAAGY_ELK1_02, CAGTGTT_MIR141_MIR200A, chr2p13, PHONG_TNF_RESPONSE_VIA_P38_COMPLETE, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, ATF6_TARGET_GENES, BRF1_TARGET_GENES, DYRK1A_TARGET_GENES, F10_TARGET_GENES, FOXN3_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C2orf42 | GOLGA6C | A6NDK9 | 720 |
| C2orf42 | RSBN1L | Q6PCB5 | 666 |
| C2orf42 | ANKRD20A2P | Q5SQ80 | 579 |
| C2orf42 | APPL2 | Q8NEU8 | 510 |
| C2orf42 | MYBBP1A | Q9BQG0 | 492 |
| C2orf42 | ZNF557 | Q8N988 | 449 |
| C2orf42 | TFPI2 | P48307 | 440 |
| C2orf42 | ADAMTS10 | Q9H324 | 431 |
| C2orf42 | SMAP2 | Q8WU79 | 428 |
| C2orf42 | POLR3H | Q9Y535 | 425 |
| C2orf42 | CALCR | P30988 | 407 |
| C2orf42 | GPR50 | Q13585 | 377 |
| C2orf42 | TNIP1 | Q15025 | 367 |
| C2orf42 | MIA3 | Q5JRA6 | 364 |
| C2orf42 | PITPNA | Q00169 | 362 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ALAS1 | C2orf42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAB2 | C2orf42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPP1R13B | C2orf42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLX3 | C2orf42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C2orf42 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| C2orf42 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| C2orf42 | PPP1R13B | psi-mi:“MI:0915”(physical association) | 0.000 |
| TLX3 | C2orf42 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C2orf42 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): C2orf42 (Two-hybrid), C2orf42 (Two-hybrid), PRKAB2 (Two-hybrid), TLX3 (Two-hybrid), HOMEZ (Two-hybrid), C2orf42 (Affinity Capture-RNA), C2orf42 (Affinity Capture-RNA), C2orf42 (Two-hybrid), C2orf42 (Two-hybrid)
ESM2 similar proteins: A2QRA0, A4IIA7, A6NHR9, B4XT64, B9F4I8, F4JSE7, P03273, P0CY36, P21784, P38899, P40434, P40889, P48752, P78746, Q03099, Q07888, Q0WL81, Q12789, Q3E7X8, Q3E7Y5, Q4R683, Q4R907, Q4WVM1, Q53NI2, Q5E9N5, Q5RAX4, Q60649, Q651A1, Q66J91, Q6P5D8, Q86UB2, Q8BLI4, Q8BMD5, Q8CBX9, Q8IPH9, Q8NG08, Q8VZF6, Q91YE9, Q93ZS1, Q96P26
Diamond homologs: Q3SYX3, Q4R907, Q8R3C1, Q9NWW7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4462 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:70150560:GTTGC:G | acceptor_gain | 1.0000 |
| 2:70150561:TTGC:T | acceptor_gain | 1.0000 |
| 2:70150562:TGC:T | acceptor_gain | 1.0000 |
| 2:70150565:C:CC | acceptor_gain | 1.0000 |
| 2:70160624:CCAA:C | donor_gain | 1.0000 |
| 2:70160796:C:CT | acceptor_gain | 1.0000 |
| 2:70160797:A:T | acceptor_gain | 1.0000 |
| 2:70160803:A:C | acceptor_gain | 1.0000 |
| 2:70160807:C:CT | acceptor_gain | 1.0000 |
| 2:70160807:C:T | acceptor_gain | 1.0000 |
| 2:70160808:A:T | acceptor_gain | 1.0000 |
| 2:70165196:CAACG:C | acceptor_gain | 1.0000 |
| 2:70165199:CG:C | acceptor_gain | 1.0000 |
| 2:70165200:G:GC | acceptor_gain | 1.0000 |
| 2:70165562:T:TA | donor_gain | 1.0000 |
| 2:70165633:TGCC:T | acceptor_loss | 1.0000 |
| 2:70165634:GCC:G | acceptor_loss | 1.0000 |
| 2:70165635:CCTA:C | acceptor_loss | 1.0000 |
| 2:70165636:C:CG | acceptor_loss | 1.0000 |
| 2:70165637:T:A | acceptor_loss | 1.0000 |
| 2:70169551:ACTT:A | donor_loss | 1.0000 |
| 2:70169552:CTTA:C | donor_loss | 1.0000 |
| 2:70169553:TTACC:T | donor_loss | 1.0000 |
| 2:70169555:A:AC | donor_gain | 1.0000 |
| 2:70169555:AC:A | donor_gain | 1.0000 |
| 2:70169555:ACCAT:A | donor_gain | 1.0000 |
| 2:70169556:C:CT | donor_gain | 1.0000 |
| 2:70169556:CC:C | donor_gain | 1.0000 |
| 2:70169556:CCA:C | donor_gain | 1.0000 |
| 2:70169556:CCAT:C | donor_gain | 1.0000 |
AlphaMissense
3734 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:70150471:A:T | I537N | 1.000 |
| 2:70150474:C:G | R536P | 1.000 |
| 2:70150477:A:G | L535P | 1.000 |
| 2:70150483:C:A | G533V | 1.000 |
| 2:70150483:C:T | G533D | 1.000 |
| 2:70150484:C:A | G533C | 1.000 |
| 2:70150484:C:G | G533R | 1.000 |
| 2:70150501:A:G | L527P | 1.000 |
| 2:70150515:C:A | W522C | 1.000 |
| 2:70150515:C:G | W522C | 1.000 |
| 2:70150516:C:G | W522S | 1.000 |
| 2:70150517:A:G | W522R | 1.000 |
| 2:70150517:A:T | W522R | 1.000 |
| 2:70150522:A:T | I520N | 1.000 |
| 2:70150528:A:G | F518S | 1.000 |
| 2:70160627:A:T | V505D | 1.000 |
| 2:70160633:A:G | L503P | 1.000 |
| 2:70160633:A:T | L503H | 1.000 |
| 2:70160762:A:G | F460S | 1.000 |
| 2:70165117:A:T | V443D | 1.000 |
| 2:70165140:C:A | W435C | 1.000 |
| 2:70165140:C:G | W435C | 1.000 |
| 2:70165141:C:G | W435S | 1.000 |
| 2:70165142:A:G | W435R | 1.000 |
| 2:70165142:A:T | W435R | 1.000 |
| 2:70165155:A:C | F430L | 1.000 |
| 2:70165155:A:T | F430L | 1.000 |
| 2:70165157:A:G | F430L | 1.000 |
| 2:70165162:C:T | G428E | 1.000 |
| 2:70165163:C:G | G428R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000048221 (2:70188686 CT>C), RS1000169294 (2:70162050 C>T), RS1000268509 (2:70168059 C>T), RS1000290168 (2:70156431 A>C), RS1000299578 (2:70163508 G>A), RS1000314656 (2:70167858 G>A), RS1000341972 (2:70156123 C>G), RS1000350250 (2:70156724 T>C), RS1000367589 (2:70157112 T>C), RS1000523866 (2:70161657 A>G), RS1000625959 (2:70157599 C>T), RS1000658252 (2:70169291 G>A), RS1000788348 (2:70163514 T>A,G), RS1000794574 (2:70174604 A>G), RS1000831732 (2:70192634 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_544 | Obesity-related traits | 6.000000e-06 |
| GCST002481_1 | Acne (severe) | 5.000000e-06 |
| GCST006661_199 | Male-pattern baldness | 3.000000e-08 |
| GCST90002397_807 | Mean spheric corpuscular volume | 4.000000e-28 |
| GCST90002398_340 | Neutrophil count | 1.000000e-15 |
| GCST90002403_110 | Red blood cell count | 9.000000e-11 |
| GCST90002407_52 | White blood cell count | 2.000000e-19 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004833 | neutrophil count |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases methylation, increases abundance | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Vehicle Emissions | decreases expression, increases abundance | 1 |
| Cannabidiol | increases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases methylation, increases abundance | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Selenium | affects cotreatment, increases expression, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vitamin E | affects cotreatment, increases expression, decreases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.